prostate-cancer

Peptide Drugs Target Prostate Cancer, Viruses, and Brain Injuries

Recent research highlights peptides as promising drugs due to their high affinity, selectivity, low toxicity, and simple synthesis. Advances include peptidomimetics that attack prostate tumors with TMPRSS2-ERG fusion, stem-derived peptides blocking Japanese encephalitis and Zika viruses, an engineered antimicrobial peptide effective against resistant bacteria, and a four-amino-acid sequence that targets injured brain tissue. These developments suggest peptides could address multiple serious conditions.